HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mikiko Ishihara Selected Research

Mikiko Ishihara Research Topics

Disease

14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 01/2012
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2018 - 03/2016
3Disease Progression
01/2019 - 01/2016
3Neoplasms (Cancer)
10/2017 - 12/2011
3Neoplasm Metastasis (Metastasis)
03/2016 - 12/2011
2Adenocarcinoma of Lung
01/2016 - 03/2013
2Leukopenia
08/2015 - 05/2014
2Lung Neoplasms (Lung Cancer)
01/2012 - 12/2011
1Exanthema (Rash)
01/2016
1Carcinoma (Carcinomatosis)
12/2015
1Infections
08/2015
1Erysipelas
08/2015
1Febrile Neutropenia
05/2014
1Neutropenia
05/2014
1Peripheral Nervous System Diseases (PNS Diseases)
05/2014
1Meningeal Carcinomatosis
03/2013
1Consciousness Disorders
03/2013
1Thymoma (Thymic Carcinoma)
01/2013
1Small Cell Carcinoma
12/2012
1Pain (Aches)
12/2011

Drug/Important Bio-Agent (IBA)

5amrubicinIBA
10/2018 - 01/2013
4ErbB Receptors (EGF Receptor)IBA
01/2019 - 01/2014
3Carboplatin (JM8)FDA LinkGeneric
12/2015 - 12/2012
3Gefitinib (Iressa)FDA Link
01/2015 - 01/2014
2osimertinibIBA
01/2019 - 01/2019
2Tyrosine Kinase InhibitorsIBA
01/2019 - 01/2016
2Pemetrexed (MTA)FDA Link
01/2016 - 01/2012
2130-nm albumin-bound paclitaxelIBA
12/2015 - 05/2014
2Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2015 - 03/2013
1NivolumabIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Pharmaceutical PreparationsIBA
10/2017
1SodiumIBA
03/2016
1alectinibIBA
01/2016
1Anaplastic Lymphoma KinaseIBA
01/2016
1Growth Factor ReceptorsIBA
01/2016
1PlatinumIBA
01/2013
1Paclitaxel (Taxol)FDA LinkGeneric
12/2012
1Bevacizumab (Avastin)FDA Link
12/2012
1Docetaxel (Taxotere)FDA Link
01/2012
1Bone Cements (Bone Glue)IBA
12/2011
1Diphosphonates (Bisphosphonates)IBA
12/2011
1StrontiumIBA
12/2011

Therapy/Procedure

11Drug Therapy (Chemotherapy)
01/2019 - 12/2012
10Therapeutics
01/2019 - 01/2012
2Radiotherapy
03/2016 - 12/2011
1Chemoradiotherapy
07/2017
1Combined Modality Therapy
03/2016
1Aftercare (After-Treatment)
03/2013
1Combination Drug Therapy (Combination Chemotherapy)
01/2013
1Activities of Daily Living (ADL)
12/2011
1Palliative Care (Palliative Therapy)
12/2011